New Journey Health Technology Group (002219.SZ) announced that its wholly-owned subsidiary, Kangxian Duyimei Biotechnology Co., Ltd. ("Duyimei..."
According to a report from Zhitongcaijing APP, New Journey Health Technology Group (002219.SZ) announced that its wholly-owned subsidiary, Kangxian Duyiwei Biopharmaceutical Co., Ltd. ("Duyiwei Pharmaceutical"), recently participated in the national procurement alliance for Chinese Patent Medicine organized by the National Procurement Office. Based on the announcement from the National Procurement Office regarding the proposed selected results for the national procurement alliance, Duyiwei Pharmaceutical's Duyiwei series products are proposed to be selected for the national procurement alliance for Chinese Patent Medicine.